diff --git a/NEWS.md b/NEWS.md
index 055782a50..3b589a830 100644
--- a/NEWS.md
+++ b/NEWS.md
@@ -8,6 +8,7 @@ It also adds a `site` argument to `as.sir()`, stores EUCAST MIC breakpoints exac
 * All explicit screening breakpoints in `clinical_breakpoints` moved to screening agents, e.g., from `FOX` to `FOX-S`, including the high-level aminoglycoside tests (`GEH` and `STH` to `GEN-S` and `STR1-S`), the topical cut-off values of EUCAST, and the CLSI surrogate tests of cefoxitin for staphylococci and pefloxacin for *Salmonella*. Use `as.sir(..., include_screening = TRUE)` to interpret a regular agent with these breakpoints; `GEH` and `STH` stay valid input (#328)
 * `include_screening` in `as.sir()` now defaults to `NULL`, using screening breakpoints for screening agents only. `include_screening = FALSE` now also returns `NA`, with a note, for a screening agent (#328)
 * EUCAST's breakpoints in brackets are no longer in `clinical_breakpoints`. They were blocking rows, so `as.sir()` can now use PK/PD breakpoints or the breakpoints of a broader taxon instead, e.g., for aminoglycosides in EUCAST 2020-2023. They stay available in [`data-raw/breakpoints_eucast_raw.csv`](https://github.com/msberends/AMR/blob/main/data-raw/breakpoints_eucast_raw.csv) (#327)
+* EUCAST breakpoints of *Vibrio* now apply only to the species that EUCAST states: *V. alginolyticus*, *V. cholerae*, *V. fluvialis*, *V. parahaemolyticus* and *V. vulnificus*. Other species and isolates identified at genus level now give `NA`, or use PK/PD breakpoints in EUCAST 2022-2023
 * With unknown `uti`, a blocking row without UTI status no longer overrides a UTI breakpoint at the same taxonomic level, e.g., amikacin in *Acinetobacter* now gives S or R instead of `NA`, which is noted in `sir_interpretation_history()`. Use `uti = FALSE` to prevent this
 * If several breakpoints fit and no `site` is set, `as.sir()` now takes the one for the most systemic site, instead of the first one in the data set. This means, e.g., that a meningitis breakpoint now precedes a non-meningitis breakpoint, such as for benzylpenicillin in *S. pneumoniae*. Use `site` to choose another one
 
diff --git a/data-raw/_reproduction_scripts/reproduction_of_clinical_breakpoints_eucast.R b/data-raw/_reproduction_scripts/reproduction_of_clinical_breakpoints_eucast.R
index 1bcf8fe84..4ec026ad3 100644
--- a/data-raw/_reproduction_scripts/reproduction_of_clinical_breakpoints_eucast.R
+++ b/data-raw/_reproduction_scripts/reproduction_of_clinical_breakpoints_eucast.R
@@ -54,6 +54,7 @@ devtools::load_all()
 parse_log <- new.env()
 parse_log$disk_dose_inherited <- NULL
 parse_log$scope_extensions <- NULL
+parse_log$scope_restrictions <- NULL
 parse_log$no_breakpoints_determined <- NULL
 
 # ==============================================================================
@@ -620,6 +621,7 @@ parse_sheet <- function(xlsx_path, sheet_name, abbreviations = list()) {
   sheet_text <- unique(parsed$full_text[!is.na(parsed$full_text) & parsed$col == 1])
   scope_pattern <- "In the absence of specific breakpoints, the ([A-Z])\\. ([a-z]+) MIC ?breakpoints can be applied to ([A-Z])\\. ([a-z]+)\\."
   bacteroides_pattern <- "Breakpoints for Bacteroides spp\\. are also valid for Parabacteroides spp\\. and for Phocaeicola dorei/vulgatus"
+  vibrio_pattern <- "Breakpoints are valid for V\\. alginolyticus, V\\. cholerae, V\\. fluvialis, V\\. parahaemolyticus and V\\. vulnificus\\."
   for (txt in sheet_text) {
     txt_squished <- gsub("\\s+", " ", txt)
     m <- regmatches(txt_squished, regexec(scope_pattern, txt_squished))[[1]]
@@ -636,7 +638,7 @@ parse_sheet <- function(xlsx_path, sheet_name, abbreviations = list()) {
           from_text = paste(genus, m[3]), to_text = paste(genus, m[5]), statement = m[1], method = "MIC"
         )
       )
-    } else if (grepl("breakpoints can (also )?be applied to [A-Z]\\.|breakpoints for .* are also valid for", txt_squished, ignore.case = TRUE) && !grepl(bacteroides_pattern, txt_squished)) {
+    } else if (grepl("breakpoints can (also )?be applied to [A-Z]\\.|breakpoints for .* are also valid for|breakpoints are (only )?valid for [A-Z]\\.", txt_squished, ignore.case = TRUE) && !grepl(paste0(bacteroides_pattern, "|", vibrio_pattern), txt_squished)) {
       stop(
         "parse_sheet(): unrecognised statement about applying breakpoints to another species on sheet '",
         sheet_name, "': ", substr(txt_squished, 1, 300)
@@ -663,6 +665,24 @@ parse_sheet <- function(xlsx_path, sheet_name, abbreviations = list()) {
     )
   }
 
+  # EUCAST limits the Vibrio breakpoints to these species, for both methods, so the rows of the genus are replaced by rows of these species in the cleanup section. Any other wording of such a statement stops the script, see above.
+  statement <- sheet_text[grepl(vibrio_pattern, gsub("\\s+", " ", sheet_text))]
+  if (length(statement) > 0) {
+    extension <- expand.grid(
+      to_text = c("Vibrio alginolyticus", "Vibrio cholerae", "Vibrio fluvialis", "Vibrio parahaemolyticus", "Vibrio vulnificus"),
+      method = c("MIC", "DISK"), stringsAsFactors = FALSE
+    )
+    statement <- regmatches(gsub("\\s+", " ", statement[1]), regexpr(vibrio_pattern, gsub("\\s+", " ", statement[1])))
+    parse_log$scope_extensions <- bind_rows(
+      parse_log$scope_extensions,
+      extension |> mutate(guideline = ver$guideline, sheet = sheet_name, from_text = "Vibrio", statement = statement)
+    )
+    parse_log$scope_restrictions <- bind_rows(
+      parse_log$scope_restrictions,
+      data.frame(guideline = ver$guideline, sheet = sheet_name, from_text = "Vibrio")
+    )
+  }
+
   # --- Detect header rows (col 2 contains "MIC breakpoint") ---
   header_rows <- parsed |>
     filter(col == 2, grepl("MIC breakpoint", base_text, fixed = TRUE)) |>
@@ -2683,6 +2703,17 @@ if (!is.null(parse_log$scope_extensions)) {
   breakpoints_eucast <- bind_rows(breakpoints_eucast, scope_rows)
 }
 
+# A statement that limits breakpoints to certain species means that the rows of the genus do not apply to its other species, so these rows go, now that the species have their own
+if (!is.null(parse_log$scope_restrictions)) {
+  restricted <- paste(parse_log$scope_restrictions$guideline, parse_log$scope_restrictions$sheet, as.character(as.mo(parse_log$scope_restrictions$from_text, info = FALSE)))
+  rows <- paste(breakpoints_eucast$guideline, breakpoints_eucast$sheet, as.character(breakpoints_eucast$mo)) %in% restricted
+  message("NOTE: ", sum(rows), " breakpoint row(s) of a genus removed following EUCAST's statement(s), in ", paste(unique(parse_log$scope_restrictions$guideline), collapse = ", "))
+  if (sum(rows) == 0 || !setequal(parse_log$scope_restrictions$guideline, paste("EUCAST", 2022:2026))) {
+    stop("unexpected result for the statement limiting the breakpoints of Vibrio to certain species")
+  }
+  breakpoints_eucast <- breakpoints_eucast[!rows, , drop = FALSE]
+}
+
 # Organisms for which EUCAST has not determined breakpoints at all ("EUCAST
 # has not determined breakpoints for Burkholderia cepacia complex organisms",
 # likewise L. pneumophila) must not be interpreted with the non-species
diff --git a/data-raw/clin_break.md5 b/data-raw/clin_break.md5
index b0bd36ebf..c60efcfa4 100644
--- a/data-raw/clin_break.md5
+++ b/data-raw/clin_break.md5
@@ -1 +1 @@
-8ec8bf482dcbf91277066759fe4f498b
+ba5a4275785b07c1c2507ade4813e79e
diff --git a/data-raw/datasets/clinical_breakpoints.dta b/data-raw/datasets/clinical_breakpoints.dta
index fb7f424a1..8356695f8 100644
Binary files a/data-raw/datasets/clinical_breakpoints.dta and b/data-raw/datasets/clinical_breakpoints.dta differ
diff --git a/data-raw/datasets/clinical_breakpoints.feather b/data-raw/datasets/clinical_breakpoints.feather
index 020c405a1..5d552a945 100644
Binary files a/data-raw/datasets/clinical_breakpoints.feather and b/data-raw/datasets/clinical_breakpoints.feather differ
diff --git a/data-raw/datasets/clinical_breakpoints.parquet b/data-raw/datasets/clinical_breakpoints.parquet
index 700617f34..1accdcb8e 100644
Binary files a/data-raw/datasets/clinical_breakpoints.parquet and b/data-raw/datasets/clinical_breakpoints.parquet differ
diff --git a/data-raw/datasets/clinical_breakpoints.rds b/data-raw/datasets/clinical_breakpoints.rds
index 2e8d9d58b..d0c7cd545 100644
Binary files a/data-raw/datasets/clinical_breakpoints.rds and b/data-raw/datasets/clinical_breakpoints.rds differ
diff --git a/data-raw/datasets/clinical_breakpoints.sav b/data-raw/datasets/clinical_breakpoints.sav
index 42b5a7e27..1c535eed7 100644
Binary files a/data-raw/datasets/clinical_breakpoints.sav and b/data-raw/datasets/clinical_breakpoints.sav differ
diff --git a/data-raw/datasets/clinical_breakpoints.txt b/data-raw/datasets/clinical_breakpoints.txt
index 8e06ae7fa..1c86e1edb 100644
--- a/data-raw/datasets/clinical_breakpoints.txt
+++ b/data-raw/datasets/clinical_breakpoints.txt
@@ -2962,38 +2962,114 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
 "EUCAST 2026"	"human"	"human"	"MIC"		"B_THMSC_RAMS"	2	"SAM"	"Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[1] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents. | [2] For susceptibility testing purposes, the concentration of sulbactam is fixed at 4 mg/L."
 "EUCAST 2026"	"human"	"human"	"DISK"		"B_THMSC_RAMS"	2	"TZP"	"Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	28	28	FALSE	FALSE	"[A] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents."
 "EUCAST 2026"	"human"	"human"	"MIC"		"B_THMSC_RAMS"	2	"TZP"	"Anaerobic bacteria_G-positive (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[1] Isolates susceptible to benzylpenicillin can be reported susceptible to all beta-lactam agents with breakpoints (including those with Note) without further testing. Isolates resistant to benzylpenicillin should be tested for susceptibility to individual agents. | [4] For susceptibility testing purposes, the concentration of  tazobactam is fixed at 4 mg/L."
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	21	21	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"ECOFF"		2	2	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"ECOFF"		1	1	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"ECOFF"		0.008	0.008	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"ERY"	"ECOFF"		16	16	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"ECOFF"		0.016	0.016	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"ECOFF"		0.125	0.125	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"TCY"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"ECOFF"		1	1	FALSE	FALSE	
-"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
-"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2026"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2026"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2026"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 16.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"CIP"	"ECOFF"		0.125	0.125	FALSE	FALSE	
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"CTX"	"ECOFF"		0.25	0.25	FALSE	FALSE	
 "EUCAST 2026"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"TCY"	"ECOFF"		4	4	FALSE	FALSE	
@@ -6035,38 +6111,114 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
 "EUCAST 2025"	"human"	"human"	"DISK"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	15	15	FALSE	FALSE	"[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2025"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 15.0)"		2	2	FALSE	FALSE	"[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_STTZR_STTZ"	2	"TZP"	"ECOFF"		4	4	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	21	21	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"ECOFF"		2	2	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"ECOFF"		1	1	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"ECOFF"		0.008	0.008	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"ERY"	"ECOFF"		16	16	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"ECOFF"		0.016	0.016	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"ECOFF"		0.125	0.125	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"TCY"	"ECOFF"		0.5	0.5	FALSE	FALSE	
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"ECOFF"		1	1	FALSE	FALSE	
-"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
-"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2025"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2025"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2025"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 15.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"CIP"	"ECOFF"		0.125	0.125	FALSE	FALSE	
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"CTX"	"ECOFF"		0.25	0.25	FALSE	FALSE	
 "EUCAST 2025"	"ECOFF"	"ECOFF"	"MIC"		"B_YERSN_ENTR"	2	"TCY"	"ECOFF"		4	4	FALSE	FALSE	
@@ -7978,28 +8130,104 @@ Positive test: Isolates with gentamicin MIC >128 mg/L denote presence of aminogl
 "EUCAST 2024"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.5	"TEC"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)"		2	2	FALSE	FALSE	"[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2024"	"human"	"human"	"DISK"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	15	15	FALSE	FALSE	"[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2024"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 14.0)"		2	2	FALSE	FALSE	"[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	21	21	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
-"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
-"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2024"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2024"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2024"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 14.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2024"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2024"	"human"	"human"	"MIC"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2024"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4	"IPM"	"Enterobacterales (file: Clinical Breakpoint Tables v. 14.0)"	"10 mcg"	50	19	FALSE	FALSE	"[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
@@ -10008,28 +10236,105 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
 "EUCAST 2023"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.6	"TZP"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)"				FALSE	FALSE	"[No breakpoint] EUCAST gives Note (see note) | [1] Benzylpenicillin (MIC or disk diffusion) can be used to screen for beta-lactam resistance in viridans group streptococci. Isolates categorised as screen negative can be reported susceptible to beta-lactam agents for which clinical breakpoints are listed (including those with \"Note\"). Isolates categorised as screen positive should be tested for susceptibility to individual agents or reported resistant. | [3] For benzylpenicillin screen negative isolates, susceptibility can be inferred from benzylpenicillin or ampicillin. For benzylpenicillin screen positive isolates, susceptibility is inferred from ampicillin. | [2] The addition of a beta-lactamase inhibitor does not add clinical benefit."
 "EUCAST 2023"	"human"	"human"	"DISK"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	15	15	FALSE	FALSE	"[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2023"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 13.1)"		2	2	FALSE	FALSE	"[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	21	21	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	
-"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
-"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to azithromycin (and erythromycin when azithromycin is not available) is inferred from the erythromycin disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"5 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"1.25/23.75 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2023"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1/A] Susceptibility to doxycycline (and tetracycline when doxycycline is not available) is inferred from the tetracycline disk diffusion test."
+"EUCAST 2023"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2023"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 13.1)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2023"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2023"	"human"	"human"	"MIC"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2023"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4	"IPM"	"Enterobacterales (file: Clinical Breakpoint Tables v. 13.1)"	"10 mcg"	50	19	FALSE	FALSE	"[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
@@ -11861,28 +12166,105 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
 "EUCAST 2022"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.6	"TZP"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives Note (see note) | [1] Benzylpenicillin (MIC or disk diffusion) can be used to screen for beta-lactam resistance in viridans group streptococci. Isolates categorised as screen negative can be reported susceptible to beta-lactam agents for which clinical breakpoints are listed (including those with \"Note\"). Isolates categorised as screen positive should be tested for susceptibility to individual agents or reported resistant. | [3] For benzylpenicillin screen negative isolates (inhibition zone >=18 mm or MIC <=0.25 mg/L), susceptibility can be inferred from benzylpenicillin or ampicillin. For benzylpenicillin screen positive isolates (inhibition zone <18 mm or MIC >0.25 mg/L), susceptibility is inferred from ampicillin. | [2] The addition of a beta-lactamase inhibitor does not add clinical benefit."
 "EUCAST 2022"	"human"	"human"	"DISK"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	15	15	FALSE	FALSE	"[B] Non-wild type isolates were not available when developing the disk diffusion method. | [1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
 "EUCAST 2022"	"human"	"human"	"MIC"		"B_STRPT_VIRI"	2.5	"VAN"	"Viridans group streptococci (file: Clinical Breakpoint Tables v. 12.0)"		2	2	FALSE	FALSE	"[1] Resistant isolates are rare or not yet reported. The identification and antimicrobial susceptibility test result on any such isolate must be confirmed and the isolate sent to a reference laboratory."
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	21	21	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
-"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI"	3	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	
-"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI"	3	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
-"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_ALGN"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_ALGN"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_CHLR"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_CHLR"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
 "EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2.1	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"				FALSE	FALSE	"[No breakpoint] EUCAST gives IE (insufficient evidence)"
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_FLVL"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_FLVL"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_PRHM"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_PRHM"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	16	16	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"AZM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		4	4	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	22	22	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CAZ"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CIP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	21	21	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"CTX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"DOX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"ERY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"15 mcg"	12	12	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to azithromycin can be inferred from the erythromycin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	23	23	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"LVX"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.25	0.25	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	24	24	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"MEM"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"PEF-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"5 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to ciprofloxacin and levofloxacin can be inferred from the pefloxacin disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"1.25/23.75 mcg"	18	18	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"SXT"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		0.5	0.5	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] Trimethoprim:sulfamethoxazole in the ratio 1:19. Breakpoints are expressed as the trimethoprim concentration."
+"EUCAST 2022"	"human"	"human"	"DISK"	"Screen"	"B_VIBRI_VLNF"	2	"TCY-S"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30 mcg"	20	20	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [A] Susceptibility to doxycycline can be inferred from the tetracycline disk diffusion screening test."
+"EUCAST 2022"	"human"	"human"	"DISK"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"	"30/6 mcg"	26	26	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus."
+"EUCAST 2022"	"human"	"human"	"MIC"		"B_VIBRI_VLNF"	2	"TZP"	"Vibrio (file: Clinical Breakpoint Tables v. 12.0)"		1	1	FALSE	FALSE	"[Scope] Breakpoints are valid for V. alginolyticus, V. cholerae, V. fluvialis, V. parahaemolyticus and V. vulnificus. | [1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
 "EUCAST 2022"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2022"	"human"	"human"	"MIC"		"B_[FAM]_MORGNLLC"	4.1	"IMR"	"Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)"				FALSE	FALSE	"[No breakpoint] EUCAST excludes Morganellaceae ('Enterobacterales except Morganellaceae')"
 "EUCAST 2022"	"human"	"human"	"DISK"		"B_[FAM]_MORGNLLC"	4	"IPM"	"Enterobacterales (file: Clinical Breakpoint Tables v. 12.0)"	"10 mcg"	50	19	FALSE	FALSE	"[2] The intrinsically low activity of imipenem against Morganella morganii, Proteus spp. and Providencia spp. requires the high exposure of imipenem."
diff --git a/data-raw/datasets/clinical_breakpoints.xlsx b/data-raw/datasets/clinical_breakpoints.xlsx
index ebaf1364d..00f03be8c 100644
Binary files a/data-raw/datasets/clinical_breakpoints.xlsx and b/data-raw/datasets/clinical_breakpoints.xlsx differ
diff --git a/data/clinical_breakpoints.rda b/data/clinical_breakpoints.rda
index 63b2b12f8..7abe135c7 100644
Binary files a/data/clinical_breakpoints.rda and b/data/clinical_breakpoints.rda differ
diff --git a/man/clinical_breakpoints.Rd b/man/clinical_breakpoints.Rd
index 24a38883b..0c30cfe6e 100644
--- a/man/clinical_breakpoints.Rd
+++ b/man/clinical_breakpoints.Rd
@@ -5,7 +5,7 @@
 \alias{clinical_breakpoints}
 \title{Data Set with Clinical Breakpoints for SIR Interpretation}
 \format{
-A \link[tibble:tibble]{tibble} with 48 382 observations and 15 variables:
+A \link[tibble:tibble]{tibble} with 48 764 observations and 15 variables:
 \itemize{
 \item \code{guideline}\cr Name of the guideline
 \item \code{type}\cr Breakpoint type, either \code{"ECOFF"}, \code{"animal"}, or \code{"human"}
@@ -49,7 +49,7 @@ The default is \code{"human"}, which can also be set with the package option \co
 
 \subsection{Blocking Rows}{
 
-Where EUCAST lists an organism but gives no breakpoint for it (e.g. "IE", "-", "Note", an organism excluded with "except", or no S category for a zone diameter), \code{\link[=as.sir]{as.sir()}} must not fall back to the breakpoint of a broader taxon, such as the breakpoint for \emph{Vibrio} spp. where EUCAST gives "IE" for \emph{V. fluvialis}. Such cases are included as "blocking rows": rows in which \code{breakpoint_S} and \code{breakpoint_R} are both \code{NA} and the \code{note} starts with \code{"[No breakpoint]"} followed by the reason. \code{\link[=as.sir]{as.sir()}} returns \code{NA} for these. This currently applies to 2 406 rows. Remove them with \code{subset(clinical_breakpoints, !is.na(breakpoint_S))} if only actual breakpoints are needed.
+Where EUCAST lists an organism but gives no breakpoint for it (e.g. "IE", "-", "Note", an organism excluded with "except", or no S category for a zone diameter), \code{\link[=as.sir]{as.sir()}} must not fall back to the breakpoint of a broader taxon, such as the breakpoint for \emph{Vibrio} spp. where EUCAST gives "IE" for \emph{V. fluvialis}. Such cases are included as "blocking rows": rows in which \code{breakpoint_S} and \code{breakpoint_R} are both \code{NA} and the \code{note} starts with \code{"[No breakpoint]"} followed by the reason. \code{\link[=as.sir]{as.sir()}} returns \code{NA} for these. This currently applies to 2 398 rows. Remove them with \code{subset(clinical_breakpoints, !is.na(breakpoint_S))} if only actual breakpoints are needed.
 
 \strong{EUCAST's breakpoints in brackets} are not in this data set. EUCAST bases these on ECOFFs, and states that reporting S or I should be avoided. \code{\link[=as.sir]{as.sir()}} therefore treats them as absent, and can use PK/PD breakpoints or, for unknown UTI status, UTI breakpoints instead. All bracketed values are kept in the \href{https://github.com/msberends/AMR/blob/main/data-raw/breakpoints_eucast_raw.csv}{raw import of the EUCAST tables} (column \code{is_bracketed}).
 
diff --git a/tests/testthat/test-data.R b/tests/testthat/test-data.R
index 682586f8c..64d927125 100644
--- a/tests/testthat/test-data.R
+++ b/tests/testthat/test-data.R
@@ -655,7 +655,9 @@ test_that("clinical_breakpoints: every blocking row of EUCAST has an effect (#32
     }
   }
   # the definition itself, on a constructed set of rows
-  rows <- cb[cb$guideline == latest & as.character(cb$ab) == "CTX" & cb$method == "MIC" & as.character(cb$mo) == "B_VIBRI", , drop = FALSE][1, ]
+  rows <- cb[cb$guideline == latest & as.character(cb$ab) == "CTX" & cb$method == "MIC" & as.character(cb$mo) == "B_VIBRI_CHLR" & cb$type == "human", , drop = FALSE][1, ]
+  rows$mo <- as.mo("Vibrio", info = FALSE)
+  rows$rank_index <- 3
   blocker <- rows
   blocker$mo <- as.mo("Vibrio fluvialis", info = FALSE)
   blocker$rank_index <- 2.1
@@ -666,6 +668,22 @@ test_that("clinical_breakpoints: every blocking row of EUCAST has an effect (#32
   expect_false(blocking_row_is_needed(1, blocker))
 })
 
+test_that("clinical_breakpoints: EUCAST breakpoints of Vibrio are for the species that EUCAST states", {
+  skip_on_cran()
+  cb <- as.data.frame(clinical_breakpoints, stringsAsFactors = FALSE)
+  cb$mo <- as.character(cb$mo)
+  cb <- cb[cb$type == "human" & cb$guideline %in% paste("EUCAST", 2022:2026), , drop = FALSE]
+  species <- as.character(as.mo(c("Vibrio alginolyticus", "Vibrio cholerae", "Vibrio fluvialis", "Vibrio parahaemolyticus", "Vibrio vulnificus"), info = FALSE))
+  vibrio <- cb[grepl("^B_VIBRI", cb$mo), , drop = FALSE]
+  expect_identical(sort(unique(vibrio$mo)), sort(species))
+  has_values <- !is.na(vibrio$breakpoint_S) | !is.na(vibrio$breakpoint_R)
+  expect_true(all(grepl("Breakpoints are valid for V. alginolyticus", vibrio$note[has_values], fixed = TRUE)))
+  # all species have the same breakpoints per year, apart from the IE of cefotaxime for V. fluvialis
+  key <- paste(vibrio$guideline, vibrio$ab, vibrio$method, vibrio$breakpoint_S, vibrio$breakpoint_R)[has_values & !(vibrio$ab == "CTX")]
+  expect_true(all(table(key) == 5))
+  expect_false(any(has_values & vibrio$ab == "CTX" & vibrio$mo == as.character(as.mo("Vibrio fluvialis", info = FALSE))))
+})
+
 test_that("clinical_breakpoints: EUCAST breakpoints stated in the Notes (#329)", {
   skip_on_cran()
   cb <- as.data.frame(clinical_breakpoints, stringsAsFactors = FALSE)
diff --git a/tests/testthat/test-sir.R b/tests/testthat/test-sir.R
index c136f6c80..cc9e14bfa 100644
--- a/tests/testthat/test-sir.R
+++ b/tests/testthat/test-sir.R
@@ -870,6 +870,11 @@ test_that("EUCAST blocking rows prevent falling back to broader breakpoints", {
   # IE for V. fluvialis, while Vibrio spp. has breakpoints
   expect_identical(sir(as.mic(0.125), "Vibrio fluvialis", "CTX", "EUCAST 2026"), NA_character_)
   expect_identical(sir(as.mic(0.125), "Vibrio cholerae", "CTX", "EUCAST 2026"), "S")
+  # breakpoints of Vibrio are for 5 species only, so not for other species or for the genus, which can only have PK/PD
+  expect_identical(sir(as.mic(0.125), "Vibrio parahaemolyticus", "CIP", "EUCAST 2026"), "S")
+  expect_identical(sir(as.mic(0.125), "Vibrio harveyi", "CIP", "EUCAST 2026"), NA_character_)
+  expect_identical(sir(as.mic(0.125), "Vibrio", "CIP", "EUCAST 2026"), NA_character_)
+  expect_identical(sir(as.mic(0.125), "Vibrio harveyi", "CIP", "EUCAST 2023"), "S")
   # fosfomycin zone diameter breakpoints apply to E. coli only
   expect_identical(sir(as.disk(25), "Klebsiella pneumoniae", "FOS", "EUCAST 2019"), NA_character_)
   expect_identical(sir(as.disk(25), "Escherichia coli", "FOS", "EUCAST 2019"), "S")